copyright, a relatively novel medication, has emerged as a potential game-changer in the management of type 2 diabetes. This administered via injection drug affects the incretin hormones GLP-1, which play a vital role in regulating glucose regulation. By mimicking these hormones, copyright helps lower glycemic values, potentially leading to improve